Search research articles
Contact Us
Filters
Showing results (311-320 of 339) with videos related to
Page
of 34
Sort By:
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
January 19, 2026
Engaging Culturally and Linguistically Diverse Communities to Prepare for Lung Cancer Screening Implementation in Australia: A Qualitative Focus Group Study
Tescha Nicholls, Sarah York, Nathan J Harrison, et al.
Journal of Medicinal Chemistry
|
October 23, 1998
6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2, 3-b]pyridine (RWJ 68354): a potent and selective p38 kinase inhibitor
J R Henry, K C Rupert, J H Dodd, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2013
Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists
John L Gilmore, James E Sheppeck, Jim Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
Identification of purine inhibitors of phosphodiesterase 7 (PDE7)
William J Pitts, Wayne Vaccaro, Tram Huynh, et al.
The Journal of Clinical Investigation
|
August 14, 2012
PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor
Alexandre Loupy, Suresh Krishna Ramakrishnan, Bharath Wootla, et al.
Scientific Reports
|
February 14, 2018
DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
Fernanda Neumann, Stéphanie Gourdain, Christelle Albac, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model
Jean M Delabar, Marco Antônio G B Gomes, Marta Fructuoso, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2008
Benzothiazole based inhibitors of p38alpha MAP kinase
Chunjian Liu, James Lin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds
T G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.
European Journal of Medicinal Chemistry
|
April 16, 2021
Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 339) with videos related to
Sort By:
Page
of 34
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
January 19, 2026
Engaging Culturally and Linguistically Diverse Communities to Prepare for Lung Cancer Screening Implementation in Australia: A Qualitative Focus Group Study
Tescha Nicholls, Sarah York, Nathan J Harrison, et al.
Journal of Medicinal Chemistry
|
October 23, 1998
6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2, 3-b]pyridine (RWJ 68354): a potent and selective p38 kinase inhibitor
J R Henry, K C Rupert, J H Dodd, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 7, 2013
Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists
John L Gilmore, James E Sheppeck, Jim Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
Identification of purine inhibitors of phosphodiesterase 7 (PDE7)
William J Pitts, Wayne Vaccaro, Tram Huynh, et al.
The Journal of Clinical Investigation
|
August 14, 2012
PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor
Alexandre Loupy, Suresh Krishna Ramakrishnan, Bharath Wootla, et al.
Scientific Reports
|
February 14, 2018
DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
Fernanda Neumann, Stéphanie Gourdain, Christelle Albac, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model
Jean M Delabar, Marco Antônio G B Gomes, Marta Fructuoso, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2008
Benzothiazole based inhibitors of p38alpha MAP kinase
Chunjian Liu, James Lin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds
T G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.
European Journal of Medicinal Chemistry
|
April 16, 2021
Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)
Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun, et al.
Page
of 34